Clinical Trials Logo

Myofascial Pain Syndromes clinical trials

View clinical trials related to Myofascial Pain Syndromes.

Filter by:

NCT ID: NCT05925855 Not yet recruiting - Clinical trials for Trigger Point Pain, Myofascial

Effect of Phonophoresis on Trigger Points

Start date: July 2023
Phase: N/A
Study type: Interventional

purpose of this study was to investigate the effects of phonophoresis with fastum gel versus reparil gel on pain intensity, pain threshold, and cervical ROM of participant with trigger point of upper trapezius.

NCT ID: NCT05925205 Recruiting - Physical Therapy Clinical Trials

Muscle Energy Technique Versus Strain Counterstrain for Upper Trapezius Myofascial Pain Syndrome

Start date: May 7, 2023
Phase: N/A
Study type: Interventional

This study will be conducted to examine the superiority of effectiveness between muscle energy technique combined with physical therapy, strain counterstrain combined with physical therapy, and physical therapy alone in terms of pain intensity, pain pressure threshold, cervical lateral flexion and rotation range of motion, and neck function for patients with upper trapezius myofascial trigger points.

NCT ID: NCT05921409 Active, not recruiting - Fibromyalgia Clinical Trials

Tool for Fibromyalgia Diagnosis and Effect of Extra Virgin Olive Oil

FIBROKIT
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

PRONACERA THERAPEUTICS S.L. is a young biotechnological company focused on the development of genetic diagnostic tools and treatments for pathologies in different medical areas such as reproduction, fibromyalgia and rare diseases or with deficiencies in diagnosis, with the aim of helping to optimize health systems through improvement in terms and forms of diagnosis. Among the multiple lines of R+D+i that are currently being developed, the reproductive genomic line and endometrial functional molecular biology stand out. Specifically, it develops the design of markers and performs the genetic analysis of infertility focused on female endometrial tissue. Fibromyalgia is a complex and common chronic pain disorder that affects 12 million Europeans. Along with other symptoms, fibromyalgia causes pain and general tenderness to touch. Currently this disease is diagnosed following the criteria established by the American College of Rheumatology (ACR) of a combination of relevant symptoms and the description of how the person feels. In other words, in practice it is a diagnosis by elimination. A patient suffering from fibromyalgia usually takes between 2 to 3 years to obtain the correct diagnosis. Health experts consider that fibromyalgia is a disease that is difficult to diagnose and that is associated with an expensive use of health system services. With FIBROKIT, Pronacera aims to design and develop a new diagnostic and monitoring tool for fibromyalgia by designing a panel of specific plasma proteome and intestinal microbiome biomarkers and reducing the number of biological samples used. During the execution of this project, the company will have three leading research and innovation organizations in the sector (Helix BioS, CINUSA and CICbioGUNE) that will support Pronacera. FIBROKIT will have a cohort of 250 participants (206 patients and 44 healthy volunteers) to validate the diagnostic capacity of the tool and perform a robust biostatistical study.

NCT ID: NCT05915598 Recruiting - Fibromyalgia Clinical Trials

Right/Left Discrimination Training on Fibromyalgia Patients

Start date: June 25, 2023
Phase: N/A
Study type: Interventional

To determine whether a targeted right/left discrimination training program can improve pain perception and functional disability in fibromyalgia patients.

NCT ID: NCT05915403 Completed - Depression Clinical Trials

Frequency of Sexual Intercourse,Women With Fibromyalgia

Start date: December 1, 2021
Phase:
Study type: Observational

Does frequency of sexual intercourse affect symptom severity in female patients with fibromyalgia?

NCT ID: NCT05910372 Recruiting - Fibromyalgia Clinical Trials

Tools for the Differential Diagnosis of Fibromyalgia Based on Cognitive Tasks

Start date: April 25, 2023
Phase:
Study type: Observational

The goal of this observational study is to test for behavioural and neurophysiological biomarkers in fibromyalgia patients. The main questions it aims to answer are: - Is there a measurable decline in working memory? - Could these measures help in fibromyalgia differential diagnosis? Participants will: - perform Color Comparison tasks - perform n-back tasks

NCT ID: NCT05907590 Recruiting - Fibromyalgia Clinical Trials

Proprioception and Interoception in Patients With Fibromyalgia

Start date: July 25, 2022
Phase:
Study type: Observational

The goal of this observational study is to learn about interoception and proprioception in patients with fibromyalgia. The main questions it aims to answer are: - Is there a significant difference in interoception between patients with fibromyalgia and healthy controls? - Is there a significant difference in proprioception between patients with fibromyalgia and healthy controls? The participants will perform: - The respiratory occlusion discrimination task - A postural control task where the effect of muscle vibration on center of gravity displacement is examined - The head repositioning accuracy task The participants will also fill out different questionnaires. Researchers will compare healthy controls to see if there is a significant difference.

NCT ID: NCT05907538 Recruiting - Fibromyalgia Clinical Trials

Interoception in Patients With Medically Unexplained Symptoms

Start date: July 25, 2022
Phase:
Study type: Observational

The goal of this observational study is to learn about interoception in patients with stress related syndromes (overstrain, burnout; SRS) and functional disorder (fibromyalgia/ chronic fatigue syndrome; FD). The main questions it aims to answer are: - Is there a significant difference in interoception between patients with SRS and healthy controls? - Is there a significant difference in interoception between patients with FD and healthy controls? - Is there a significant difference in interoception between patients with SRS and FD? The participants will perform the respiratory occlusion discrimination task and have to fill out some questionnaires. Researchers will compare healthy controls to see if there is a significant difference.

NCT ID: NCT05905159 Completed - Fibromyalgia Clinical Trials

Attentional Bias Modification in Fibromyalgia Patients (ABM)

ABM
Start date: January 12, 2023
Phase: N/A
Study type: Interventional

There is a growing interest in the potential benefits of attentional bias modification (ABM) training in chronic pain patients. However, studies examining the effectiveness of ABM programs in fibromyalgia patients have demonstrated inconclusive effects on both behavioral indices and clinical symptoms. Underlying neural dynamics of ABM effects could yield additional insights but remain yet unexplored. Current study, therefore, aimed investigating the effects of ABM training on known neural indicators of attentional bias to pain using electroencephalography (EEG). The goal of this clinical trial is to test the effects of ABM training on known neural indicators of attentional bias to pain using electroencephalography (EEG) in fibromyalgia patients The main question[s] it aims to answer are: - Are fibromyalgia patients sensitive to ABM procedures? - What are the neural indices associated with ABM procedures? - Do ABM procedures transfer of effects on the clinical symptomatology in fibromyalgia patients? Participants will performes five sessions consisting of a modified dot-probe task in which patients were trained to avoid facial pain expressions, whereas in the control group participants will performes five sessions consisting of a standard dot-probe task. Potential ABM training effects will be evaluated by comparing a single pre- and post-treatment session, in which event-related potentials (ERPs) will be recorded in response to three experimental tasks (standard dot-probe, RIR, and visual tasks). Furthermore, patients will fill a series of self-report questionnaires assessing anxiety, depression, pain-related worrying, fear of pain, fatigue and pain status. Researchers will compare two fibromyalgia patients groups that will enrolled and randomly assigned to an ABM training in order to see attentional improvements in the training fibromyalgia group.

NCT ID: NCT05904990 Completed - Fibromyalgia Clinical Trials

High-intensity Laser Therapy Improves Pain, Health Status and Quality of Life in Women With Fibromyalgia

Start date: January 29, 2023
Phase: N/A
Study type: Interventional

This study will be conducted to investigate High-intensity laser therapy improves pain, health status and quality of life in women with fibromyalgia